Inspection classificationInspection ended April 14, 2026

FDA inspection of Baylor, Scott, and White, ART Program: NAI

No action indicated

FDA's record ↗

FDA classified an inspection of Baylor, Scott, and White, ART Program in Temple, TX as NAI (no action indicated). The inspection ended on April 14, 2026. Product type: Biologics.

On the record

Establishment
Baylor, Scott, and White, ART Program
Location
Temple, TX
Classification
NAI · No action indicated
Inspection ended
2026-04-14
Product type
Biologics
Fiscal year
FY2026
FDA establishment identifier (FEI)
3031507074
Source
FDA Data Dashboard ↗

The full record

An account shows the project areas inspected and whether citations were posted.

What an inspection classification is

After an inspection FDA classifies the outcome. NAI (no action indicated): no objectionable conditions were found, or none that justify further action. VAI (voluntary action indicated): objectionable conditions were found, but the agency is not prepared to take or recommend regulatory action. OAI (official action indicated): regulatory or administrative action is recommended.

More

Watch Baylor, Scott, and White, ART Program

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA Data Dashboard; FDA posts a classification after its review, which can be months after the inspection ended. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Baylor, Scott, and White, ART Program.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.